WHO may drop ‘counterfeit’ from its substandard drugs definition; move won't affect national legislation
The World Health Organisation is considering a recommendation that it drops use of the term ‘counterfeit’ when referring to drugs and other medical products that appear to fail regulatory standards and lack relevant approvals.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.